SCHEMBL333161

SCHEMBL333161

Nc1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.62
LMNA P02545 3/20 0.62
POLB P06746 3/20 0.62
HTT P42858 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
ALDH1A1 P00352 3/20 0.58
CYP3A4 P08684 1/20 0.58
ALOX15 P16050 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
GAA P10253 2/20 0.58
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
MAPK1 P28482 2/20 0.56
MAPK14 Q16539 1/20 0.55
CES2 O00748 2/20 0.55
CES1 P23141 1/20 0.54
CYP19A1 P11511 1/20 0.53
TP53 P04637 1/20 0.53
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6815300 1.00 MAPT (0.62) MAPTLMNAPOLBHTTSMN1; SMN2
Methyl Alcohol SCHEMBL28297623 0.97 MAPT (0.59) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL2923533 0.90 ALDH1A1 (0.69) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL7706024 0.89 TSHR (0.63) MAPTLMNAPOLBHTTSMN1; SMN2
Methylamine SCHEMBL28159482 0.88 ALDH1A1 (0.65) MAPTLMNAPOLBHTTSMN1; SMN2
Methyl Alcohol SCHEMBL28228743 0.88 ALDH1A1 (0.65) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL11846252 0.86 MAPT (0.61) MAPTLMNAHTTSMN1; SMN2ALDH1A1
SCHEMBL11849885 0.86 ALDH1A1 (0.58) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL6815296 0.86 LMNA (0.58) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL11010668 0.85 LMNA (0.60) MAPTLMNAPOLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120079371-A Oxygen vacancy-containing tungsten trioxide catalyst and preparation method and application thereof 南京理工大学 2025-06-03 CN claimed
CN-119098205-A Nitrogen-doped porous carbon-loaded cobalt monoatomic catalyst and preparation method and application thereof 南京理工大学 2024-12-10 CN claimed
CN-117996204-A Manufacturing method of in-situ curing electrolyte battery and battery 北京卫蓝新能源科技有限公司 2024-05-07 CN claimed
CN-113501793-A Preparation method of stable isotope labeled nitrazepam internal standard reagent 谱同生物医药科技(常州)有限公司 2021-10-15 CN claimed
CN-113121726-A Composition containing bisimidazole photoinitiator and application thereof 优缔贸易(上海)有限公司 2021-07-16 CN claimed
CN-112795017-A Preparation method of silicone rubber with polar functional groups 张爱民 2021-05-14 CN claimed
CN-111231468-A Heat-insulation fabric 安徽弋尚纺织科技有限公司 2020-06-05 CN claimed
EP-3470491-A1 PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS The Chemours Company FC, LLC (US) 2019-04-17 EP claimed
EP-2410032-B1 Phosphorus-containing stabilizers for fluoroolefins CHEMOURS CO FC LLC (US) 2018-11-14 EP claimed
US-10092786-B2 Fire extinguishing composition comprising aldoketones compound XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) 2018-10-09 US claimed
WO-2007126760-A2 COMPOSITIONS COMPRISING IODOTRIFLUOROMETHANE AND STABILIZERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-11-08 WO claimed
US-7087641-B2 4β-1″-[(2″-substituted benzoyl) anilino]podophyllotoxin analogues useful as anticancer agents COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2006-08-08 US claimed
EP-1377588-B1 4-BETA-1''-[(2''-(SUBSTITUTED BENZOYL)ANILINO] PODOPHYLLOTOXIN ANALOGUES USEFUL AS ANTICANCER AGENTS COUNCIL SCIENT IND RES (IN) 2005-08-10 EP claimed
US-20050101804-A1 4Beta-1\"-{2'-substituted benzoyl) anilino] podophyllotoxin analogues useful as anticancer agents COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2005-05-12 US claimed
EP-1377588-A1 4-BETA-1''-[(2''-(SUBSTITUTED BENZOYL)ANILINO] PODOPHYLLOTOXIN ANALOGUES USEFUL AS ANTICANCER AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-01-07 EP claimed
WO-2003082876-A1 4-BETA-1''-`(2''-(SUBSTITUTED BENZOYL)ANILINO! PODOPHYLLOTOXIN ANALOGUES USEFUL AS ANTICANCER AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-10-09 WO claimed
CN-1064960-C Method for preparation of nitrazepam NO 8 BRANCH OF HUBEI PHARMACEU (CN) 2001-04-25 CN claimed
CN-1098410-A The preparation method of surem HUBEI PHARMACEUTICAL FACTORY N (CN) 1995-02-08 CN claimed
EP-0022017-B1 DERIVATIVES OF 2-BENZOYL-4-NITRO ANILIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES PIERRE FABRE S.A. (FR) 1982-05-05 EP claimed
US-4102881-A REACTING 2-AMINOBENZOPHENONES WITH ALKYL ORTHO-HALO-ACETATE THEN WITH AN ALKALI METAL AZIDE, SUBJECTING TO REDUCTIVE RING CLOSURE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1978-07-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101804-A1 4Beta-1\"-{2'-substituted benzoyl) anilino] podophyllotoxin analogues useful as anticancer agents TUBB4A, CASP4, TUBB4B MAPT 3491/4885LMNA 190/4885POLB 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.